Chimera Investment (NYSE:CIM) Sets New 1-Year Low – What’s Next?

Shares of Chimera Investment Co. (NYSE:CIM) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $10.78 and last traded at $10.99, with a volume of 178101 shares traded. The stock had previously closed at $11.74.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Royal Bank of Canada raised Chimera Investment to a “moderate buy” rating in a research note on Friday, March 14th. JMP Securities reaffirmed a “market perform” rating on shares of Chimera Investment in a research note on Thursday, January 23rd. Finally, StockNews.com cut shares of Chimera Investment from a “buy” rating to a “hold” rating in a research report on Thursday, February 13th.

Chimera Investment Price Performance

The company has a debt-to-equity ratio of 2.82, a current ratio of 0.06 and a quick ratio of 3.03. The firm has a market capitalization of $845.24 million, a price-to-earnings ratio of 9.67 and a beta of 1.47. The stock has a 50 day moving average price of $13.66 and a two-hundred day moving average price of $14.46.

Chimera Investment (NYSE:CIM) last issued its quarterly earnings results on Wednesday, February 12th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.10). Chimera Investment had a return on equity of 7.00% and a net margin of 20.28%. As a group, analysts expect that Chimera Investment Co. will post 1.57 EPS for the current year.

Chimera Investment Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 14.17%. The ex-dividend date is Monday, March 31st. Chimera Investment’s dividend payout ratio is currently 137.04%.

Insider Activity

In related news, Director Gerard Creagh acquired 12,500 shares of the stock in a transaction dated Tuesday, March 11th. The stock was acquired at an average cost of $13.31 per share, with a total value of $166,375.00. Following the completion of the transaction, the director now owns 138,127 shares in the company, valued at $1,838,470.37. This represents a 9.95 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.91% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CIM. GAMMA Investing LLC lifted its position in shares of Chimera Investment by 8,728.6% during the 1st quarter. GAMMA Investing LLC now owns 3,708 shares of the real estate investment trust’s stock worth $48,000 after purchasing an additional 3,666 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Chimera Investment during the 4th quarter worth about $207,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Chimera Investment in the 4th quarter valued at about $299,000. PharVision Advisers LLC purchased a new position in shares of Chimera Investment in the 4th quarter valued at about $178,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Chimera Investment by 19.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 176,381 shares of the real estate investment trust’s stock worth $2,469,000 after purchasing an additional 28,760 shares during the last quarter. Institutional investors and hedge funds own 48.44% of the company’s stock.

Chimera Investment Company Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.